TCRep 3D: An Automated In Silico Approach to Study the Structural Properties of TCR Repertoires

TCRep 3D is an automated systematic approach for TCR-peptide-MHC class I structure prediction, based on homology and ab initio modeling. It has been considerably generalized from former studies to be applicable to large repertoires of TCR. First, the location of the complementary determining regions of the target sequences are automatically identified by a sequence alignment strategy against a database of TCR Vα and Vβ chains. A structure-based alignment ensures automated identification of CDR3 loops. The CDR are then modeled in the environment of the complex, in an ab initio approach based on a simulated annealing protocol. During this step, dihedral restraints are applied to drive the CDR1 and CDR2 loops towards their canonical conformations, described by Al-Lazikani et. al. We developed a new automated algorithm that determines additional restraints to iteratively converge towards TCR conformations making frequent hydrogen bonds with the pMHC. We demonstrated that our approach outperforms popular scoring methods (Anolea, Dope and Modeller) in predicting relevant CDR conformations. Finally, this modeling approach has been successfully applied to experimentally determined sequences of TCR that recognize the NY-ESO-1 cancer testis antigen. This analysis revealed a mechanism of selection of TCR through the presence of a single conserved amino acid in all CDR3β sequences. The important structural modifications predicted in silico and the associated dramatic loss of experimental binding affinity upon mutation of this amino acid show the good correspondence between the predicted structures and their biological activities. To our knowledge, this is the first systematic approach that was developed for large TCR repertoire structural modeling.

[1]  Andrew Sewell,et al.  Structural and kinetic basis for heightened immunogenicity of T cell vaccines , 2005, The Journal of experimental medicine.

[2]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.

[3]  M. Bonneville,et al.  Prevalent Role of TCR α-Chain in the Selection of the Preimmune Repertoire Specific for a Human Tumor-Associated Self-Antigen1 , 2003, The Journal of Immunology.

[4]  D. Wiley,et al.  Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids. , 1998, Immunity.

[5]  J. Deisenhofer,et al.  Crystal structure of a T cell receptor Valpha11 (AV11S5) domain: new canonical forms for the first and second complementarity determining regions. , 2001, Journal of molecular biology.

[6]  T. Schumacher,et al.  Evidence for a TCR Affinity Threshold Delimiting Maximal CD8 T Cell Function , 2010, The Journal of Immunology.

[7]  J. Fontecilla-Camps,et al.  The three-dimensional structure of a T-cell antigen receptor V alpha V beta heterodimer reveals a novel arrangement of the V beta domain. , 1997, The EMBO journal.

[8]  B. Braden,et al.  Crystal structure of the V alpha domain of a T cell antigen receptor. , 1995, Science.

[9]  Hongmin Li,et al.  Structures of two streptococcal superantigens bound to TCR beta chains reveal diversity in the architecture of T cell signaling complexes. , 2002, Structure.

[10]  A. Sali,et al.  Modeling of loops in protein structures , 2000, Protein science : a publication of the Protein Society.

[11]  A M Lesk,et al.  Canonical structures for the hypervariable regions of T cell alphabeta receptors. , 2000, Journal of molecular biology.

[12]  Philip J. R. Goulder,et al.  Phenotypic Analysis of Antigen-Specific T Lymphocytes , 1996, Science.

[13]  A. Smolyar,et al.  Atomic structure of an αβ T cell receptor (TCR) heterodimer in complex with an anti‐TCR Fab fragment derived from a mitogenic antibody , 1998, The EMBO journal.

[14]  A. Sali,et al.  Statistical potential for assessment and prediction of protein structures , 2006, Protein science : a publication of the Protein Society.

[15]  K. Garcia,et al.  A functional hot spot for antigen recognition in a superagonist TCR/MHC complex. , 2000, Immunity.

[16]  M Karplus,et al.  Modeling of the TCR-MHC-peptide complex. , 2000, Journal of molecular biology.

[17]  J. Thornton,et al.  Satisfying hydrogen bonding potential in proteins. , 1994, Journal of molecular biology.

[18]  B. Braden,et al.  Crystal Structure of the Vα Domain of a T Cell Antigen Receptor , 1995, Science.

[19]  L R Pease,et al.  Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. , 1998, Science.

[20]  C. Thompson,et al.  Chicken T-cell receptor beta-chain diversity: an evolutionarily conserved D beta-encoded glycine turn within the hypervariable CDR3 domain. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[21]  D. Speiser,et al.  Ex vivo detectable human CD8 T-cell responses to cancer-testis antigens. , 2006, Cancer research.

[22]  Mark M Davis,et al.  How T cells 'see' antigen , 2005, Nature Immunology.

[23]  J. Fontecilla-Camps,et al.  The three‐dimensional structure of a T‐cell antigen receptor VαVβ heterodimer reveals a novel arrangement of the Vβ domain , 1997 .

[24]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[25]  David I Stuart,et al.  A structural basis for immunodominant human T cell receptor recognition , 2003, Nature Immunology.

[26]  Jérôme Lane,et al.  IMGT®, the international ImMunoGeneTics information system® , 2004, Nucleic Acids Res..

[27]  Brian M. Baker,et al.  Conformational changes and flexibility in T-cell receptor recognition of peptide–MHC complexes , 2008, The Biochemical journal.

[28]  R. Ober,et al.  The central residues of a T cell receptor sequence motif are key determinants of autoantigen recognition in murine experimental autoimmune encephalomyelitis , 2005, European journal of immunology.

[29]  I. Wilson,et al.  Crystal structure of an isolated V(alpha) domain of the 2C T-cell receptor. , 2001, Journal of molecular biology.

[30]  Robyn L. Stanfield,et al.  An αβ T Cell Receptor Structure at 2.5 Å and Its Orientation in the TCR-MHC Complex , 1996, Science.

[31]  Olivier Michielin,et al.  A Novel Population of Human Melanoma-Specific CD8 T Cells Recognizes Melan-AMART-1 Immunodominant Nonapeptide but Not the Corresponding Decapeptide1 , 2007, The Journal of Immunology.

[32]  Sarah A. Teichmann,et al.  Principles of protein-protein interactions , 2002, ECCB.

[33]  Bernard Malissen,et al.  What do TCR-pMHC crystal structures teach us about MHC restriction and alloreactivity? , 2003, Trends in immunology.

[34]  Ian A Wilson,et al.  The specificity of TCR/pMHC interaction. , 2002, Current opinion in immunology.

[35]  Cyrus Chothia,et al.  Canonical structures for the hypervariable regions of T cell αβ receptors 1 1 Edited by J. M. Thornton , 2000 .

[36]  F. Melo,et al.  Novel knowledge-based mean force potential at atomic level. , 1997, Journal of molecular biology.

[37]  J. Whisstock,et al.  A Structural Basis for the Selection of Dominant αβ T Cell Receptors in Antiviral Immunity , 2003 .

[38]  G. Gao,et al.  Germ Line-governed Recognition of a Cancer Epitope by an Immunodominant Human T-cell Receptor* , 2009, The Journal of Biological Chemistry.

[39]  V. Zoete,et al.  MM–GBSA binding free energy decomposition and T cell receptor engineering , 2010, Journal of molecular recognition : JMR.

[40]  E. Kawasaki,et al.  A general method for facilitating heterodimeric pairing between two proteins: application to expression of alpha and beta T-cell receptor extracellular segments. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[41]  T. Blundell,et al.  Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.

[42]  Partho Ghosh,et al.  Structure of the complex between human T-cell receptor, viral peptide and HLA-A2 , 1996, Nature.

[43]  Ettore Appella,et al.  A correlation between TCR Valpha docking on MHC and CD8 dependence: implications for T cell selection. , 2003, Immunity.

[44]  Robyn L Stanfield,et al.  How TCRs bind MHCs, peptides, and coreceptors. , 2006, Annual review of immunology.

[45]  R. Mariuzza,et al.  Crystal structure of the beta chain of a T cell antigen receptor. , 1995, Science.

[46]  P. Romero,et al.  Vaccination with a Melan-A Peptide Selects an Oligoclonal T Cell Population with Increased Functional Avidity and Tumor Reactivity1 , 2002, The Journal of Immunology.

[47]  Bernard Malissen,et al.  A T cell receptor CDR3beta loop undergoes conformational changes of unprecedented magnitude upon binding to a peptide/MHC class I complex. , 2002, Immunity.

[48]  D. Speiser,et al.  Distinct sets of αβ TCRs confer similar recognition of tumor antigen NY-ESO-1157–165 by interacting with its central Met/Trp residues , 2008, Proceedings of the National Academy of Sciences.

[49]  G. Ogg,et al.  Ex Vivo Staining of Metastatic Lymph Nodes by Class I Major Histocompatibility Complex Tetramers Reveals High Numbers of Antigen-experienced Tumor-specific Cytolytic T Lymphocytes , 1998, The Journal of experimental medicine.

[50]  James McCluskey,et al.  A structural basis for the selection of dominant alphabeta T cell receptors in antiviral immunity. , 2003, Immunity.

[51]  E. Padlan,et al.  The X-ray crystal structure of a Valpha2.6Jalpha38 mouse T cell receptor domain at 2.5 A resolution: alternate modes of dimerization and crystal packing. , 1999, Journal of molecular biology.

[52]  James McCluskey,et al.  Hard wiring of T cell receptor specificity for the major histocompatibility complex is underpinned by TCR adaptability , 2010, Proceedings of the National Academy of Sciences.

[53]  J. Boulter,et al.  Crystal structures of high affinity human T-cell receptors bound to peptide major histocompatibility complex reveal native diagonal binding geometry. , 2007, Protein engineering, design & selection : PEDS.

[54]  Jens Stoye,et al.  A Novel Approach to Remote Homology Detection: Jumping Alignments , 2002, J. Comput. Biol..

[55]  P. Anton van der Merwe,et al.  CDR3 loop flexibility contributes to the degeneracy of TCR recognition , 2003, Nature Immunology.